Concourse Financial Group Securities, Inc. Axogen, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 606 shares of AXGN stock, worth $8,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
606
Previous 606
-0.0%
Holding current value
$8,890
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AXGN
# of Institutions
129Shares Held
35.8MCall Options Held
79.1KPut Options Held
500-
Arrow Mark Colorado Holdings LLC Denver, CO5.12MShares$75.1 Million0.49% of portfolio
-
First Light Asset Management, LLC Edina, MN3.34MShares$49.1 Million2.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.31MShares$48.5 Million2.42% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$47.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.52MShares$37 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $620M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...